Diagnostic Impact of CSF Biomarkers in a Local Hospital Memory Clinic Revisited
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Diagnostic Impact of CSF Biomarkers in a Local Hospital Memory Clinic Revisited ; volume:49 ; number:1 ; year:2020 ; pages:2-7
Dementia and geriatric cognitive disorders ; 49, Heft 1 (2020), 2-7
- Urheber
-
Boelaarts, Leo
de Jonghe, Jos F.M.
Scheltens, Philip
- DOI
-
10.1159/000506332
- URN
-
urn:nbn:de:101:1-2020100100255598292983
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:45 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Boelaarts, Leo
- de Jonghe, Jos F.M.
- Scheltens, Philip
Ähnliche Objekte (12)
Heterogeneity of Alzheimer’s disease: consequence for drug trials?
A decade of Alzheimer’s Research & Therapy: reflections on the past, present, and future
Synaptic proteins in CSF as potential novel biomarkers for prognosis in prodromal Alzheimer’s disease
Unbiased estimates of cerebrospinal fluid β-amyloid 1–42 cutoffs in a large memory clinic population
Discordant amyloid-β PET and CSF biomarkers and its clinical consequences
Prevention of depression and sleep disturbances in elderly with memory-problems by activation of the biological clock with light - a randomized clinical trial
The “rights” of precision drug development for Alzheimer’s disease
Testing Episodic Memory in Elderly Subjects: Not as Simple as It Looks
Eyes-closed task-free electroencephalography in clinical trials for Alzheimer’s disease: an emerging method based upon brain dynamics
Clinical Features of Patients with Alzheimer’s Disease and a History of Traumatic Brain Injury
Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies
Practical use of visual medial temporal lobe atrophy cut-off scores in Alzheimer’s disease: Validation in a large memory clinic population
Heterogeneity of Alzheimer’s disease: consequence for drug trials?
A decade of Alzheimer’s Research & Therapy: reflections on the past, present, and future
Synaptic proteins in CSF as potential novel biomarkers for prognosis in prodromal Alzheimer’s disease
Unbiased estimates of cerebrospinal fluid β-amyloid 1–42 cutoffs in a large memory clinic population
Discordant amyloid-β PET and CSF biomarkers and its clinical consequences
Prevention of depression and sleep disturbances in elderly with memory-problems by activation of the biological clock with light - a randomized clinical trial
The “rights” of precision drug development for Alzheimer’s disease
Testing Episodic Memory in Elderly Subjects: Not as Simple as It Looks
Eyes-closed task-free electroencephalography in clinical trials for Alzheimer’s disease: an emerging method based upon brain dynamics
Clinical Features of Patients with Alzheimer’s Disease and a History of Traumatic Brain Injury
Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies
Practical use of visual medial temporal lobe atrophy cut-off scores in Alzheimer’s disease: Validation in a large memory clinic population
Heterogeneity of Alzheimer’s disease: consequence for drug trials?
A decade of Alzheimer’s Research & Therapy: reflections on the past, present, and future
Synaptic proteins in CSF as potential novel biomarkers for prognosis in prodromal Alzheimer’s disease
Unbiased estimates of cerebrospinal fluid β-amyloid 1–42 cutoffs in a large memory clinic population
Discordant amyloid-β PET and CSF biomarkers and its clinical consequences
Prevention of depression and sleep disturbances in elderly with memory-problems by activation of the biological clock with light - a randomized clinical trial
The “rights” of precision drug development for Alzheimer’s disease
Testing Episodic Memory in Elderly Subjects: Not as Simple as It Looks
Eyes-closed task-free electroencephalography in clinical trials for Alzheimer’s disease: an emerging method based upon brain dynamics
Clinical Features of Patients with Alzheimer’s Disease and a History of Traumatic Brain Injury
Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies